TELA Bio (TELA) Total Liabilities (2018 - 2026)

TELA Bio has reported Total Liabilities for 9 years, with the latest figure at $75.6 million in Q2 2026.

• On a quarterly basis, Total Liabilities rose 29.56% year-over-year to $75.6 million in Q2 2026; TTM through Jun 2026 was $75.6 million, a 29.56% increase from a year earlier, with the FY2025 full-year figure at $75.1 million, up 29.24% from the prior year.
• Total Liabilities was $75.6 million for Q2 2026 at TELA Bio, up from $75.1 million in the prior quarter.
• The five-year high for Total Liabilities was $75.6 million in Q2 2026, with the low at $45.3 million in Q1 2022.
• Average Total Liabilities over 5 years is $59.4 million, with a median of $57.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities soared 36.96% in 2022, then dropped 1.78% in 2024.
• Over 5 years, Total Liabilities stood at $53.6 million in 2022, then gained by 10.49% to $59.2 million in 2023, then dropped by 1.78% to $58.1 million in 2024, then gained by 29.24% to $75.1 million in 2025, then increased by 0.66% to $75.6 million in 2026.
• The last three Total Liabilities figures came in at $75.6 million (Q2 2026), $75.1 million (Q1 2026), and $75.1 million (Q4 2025), per Business Quant data.